indoline has been researched along with Carcinogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Diao, A; Jing, L; Li, Y; Song, N; Wang, A; Wang, J; Yu, P; Zeng, F; Zhao, M | 1 |
1 other study(ies) available for indoline and Carcinogenesis
| Article | Year |
|---|---|
2-(2-nitrobenzylidene) indolin-3-one compound inhibits transmembrane prostate androgen-induced protein (TMEPAI) expression and cancer cell proliferation.
Topics: Carcinogenesis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; G1 Phase; HeLa Cells; Hep G2 Cells; Humans; Indoles; Membrane Proteins; Promoter Regions, Genetic | 2018 |